Prolonged response after stopping TPO-RA in ITP, TP53 mutations and myelofibrosis outcomes, clinical picture of ERCC6L2 disease, where variants predispose to marrow failure and malignancy
0
0
0 Mga view·
06/08/23
Magpakita ng higit pa
0 Mga komento
sort Pagbukud-bukurin Ayon